laao
(2)
Conformal Medical
Conformal Medical is a Nashua, New Hampshire medical device company developing the CLAAS AcuFORM System, a next-generation left atrial appendage occlusion (LAAO) implant that uses a proprietary foam matrix to seal the left atrial appendage and reduce stroke risk in patients with non-valvular atrial fibrillation. Its design conforms to a wide range of anatomies with only two device sizes, and is intended to make LAAO a same-day, single-operator procedure that can avoid general anesthesia and transesophageal echocardiography. In February 2026 the company became a wholly owned subsidiary of W. L. Gore & Associates.
James Reinstein
James Reinstein is the President and CEO of Conformal Medical, a New Hampshire medical device company building next-generation left atrial appendage occlusion (LAAO) technology to reduce stroke risk in patients with atrial fibrillation. A three-decade medtech operator, he spent 17 years at Boston Scientific in commercial leadership across Asia, Europe and Latin America before running a string of device companies as CEO, including Cutera, Drawbridge Health, Aptus Endosystems and Saranas. Known for insisting that a device company think commercially from day one, he took the helm at Conformal in 2022 to guide its foam-based CLAAS system through pivotal trials toward market.